Cwestiwn ysgrifenedig WQ91510
- Gofynnwyd gan
- Rhys ab OwenAnnibynnol
- I'w ateb gan
- Minister for Health and Social Services
- Cyflwynwyd
- Dyddiad ateb
- Atebwyd
- Amser i'w ateb
- 12 diwrnod
Cwestiwn
Mae'r cwestiwn a'r ateb yn Saesneg gan nad oes fersiwn Gymraeg ar gael.
Further to WQ91377, what support is given to streamlining BCRA mutation testing for people who are predisposed to mutations but without first or second-degree familial cancer diagnoses, especially when referring to familial connections who have received testing outside of the UK?
Ateb
Atebwyd gan Minister for Health and Social Services
BRCA gene testing is not routinely offered for people with no family history of cancer, unless they are affected by cancer themselves or there is confirmed familial predisposition with a pathogenic gene alteration identified in a relative.
When people have a relative with a pathogenic gene alteration identified through testing overseas, the All Wales Medical Genomics Service (AWMGS) would obtain signed consent from the relative via the patient to contact the testing centre for further information to support the patient.
Throughout the process, people would have access to the same information and support from AWMGS as those with familial connections tested in the UK. This approach is in accordance with NICE guidance and National Genomic Test Directory.